The mammalian cochlea is a gem often overlooked by developmental biologists. Highly complex in function, it is nevertheless highly ordered in morphology. There are clear gradients along the principal axis of the organ: in length and number of the sensory hair cells; in height, orientation, and number of sensory cilia; and in width, thickness, and stiffness of the basilar membrane. These architectural features presumably reflect transient gradients of morphogenic factors and may be sensitive assays for experimental manipulation of such factors.
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Understanding development of the cochlea should also have a tremendous impact on public health. More than a third of us will have substantial hearing loss by old age, most of it resulting from the death of sensory hair cells. We are born with a complement of but 30,000 hair cells; like neurons, they do not regenerate, so most hearing loss is irreversible. A few laboratories are trying to understand the factors involved in hair-cell development in order to stimulate regeneration from stem cells or dedifferentiated supporting cells. Although no one underestimates the difficulty of the task, it may be the only possible strategy for recovery from most sensorineural deafness. In understanding what makes a cell become a hair cell, much of the research is directed at expression and function of transcription factors in the inner ear. Receptors for retinoic acid and thyroid hormone have received most of the attention, both because these are well understood and because alterations in retinoic acid or thyroid hormone during development are known to cause inner ear defects. In this context, two recent papers take on particular interest. Bradley et al. (1) have used in situ hybridization to understand the spatial and temporal pattern of expression ofthe thyroid hormone receptors (TRs) in the developing ear.
Both /3 forms of TR are expressed only in the cochlear portion of the inner ear at embryonic day 12 (E12) in rat, whereas the a form appears in both cochlear and vestibular regions. In a study recently reported by Kelley et al. (2) cultured explants of developing cochlea from E13-E16 in mouse and found that addition of retinoic acid alters cell fate so as to produce more hair cells.
Inner Ear Development
The organs of the inner ear are derived from the otic placode, a region of surface and neural ectoderm on the lateral rhombencephalon that invaginates and pinches off to form a closed sack, the otic vesicle (3, 4) . Elongations and distortions of the otic vesicle then create the six separate organs of the mammalian inner ear: the sacculus, the utriculus, and the three semicircular canals of the vestibular system, and the snail-shaped cochlea responsible for auditory sensation (Fig.  1 (5) . At E16 in mouse, the cochlea is little more than an elongated sack (Fig. 2) axons to the cochlear nucleus in the brainstem. It is not hard to imagine that the mammalian cochlea requires the synchronized action of many highly specific transcriptional factors to orchestrate its development.
Transcription Factors
The spatial and temporal enactment of developmental events depends to a large extent on selected patterns of transcriptional regulation. This is an extremely intricate process with many "dimensions of complexity" (6) that is only beginning to be understood. The two main components of transcriptional regulation are DNA-binding motifs (at least 12 distinct types) and protein transcriptional factors (perhaps up to 5000), which have a DNAbinding domain, a regulatory domain, and sometimes a ligand-binding domain (6) . There Components of the thyroid hormone system include the ligands L-thyroxine (T4) and 3,5,3'-triiodothyronine (T3), and the TRs. After crossing the cell membrane, T4 is deiodinated to T3, which binds TRs. The receptors are encoded by two genes, c-erbAa and c-erbA/3, which in turn can undergo alternative splicing to yield three functional receptors, TRal, TR,B1, and TRP2 (10 (15) (16) (17) . In addition, exposure of embryonic otic vesicles to retinoic acid in culture induces a precocious differentiation of the sensory epithelium and the secretory and supporting epithelium (18) . In situ hybridization analysis of mRNAs encoding the proteins involved in mediating the retinoic acid response reveal that RAR/3 is strongly expressed in the mesenchyme as well as in the sensory epithelium of the developing ear (9) . Interestingly, the retinoic acid-binding protein CRABP II, which is thought to be involved in controlling the intracellular concentrations of free retinoids, is finely localized within the cochlear epithelium during development (19 (2) showed that most of the extra hair cells were born before E14, suggesting that retinoic acid increased hair cell number by altering the fate of existing cells, rather than by stimulating proliferation of precursor cells. The efficacy of retinoic acid in producing extra hair cells depended critically on age, dropping dramatically between E14 and E17. The dose-response curve suggests that retinoic acid is acting through an RAR rather than an RXR.
By culturing explants on the F9 reporter cell line, which responds to retinoic acid by expressing ,3-galactosidase, Kelley et al. (2) also showed that developing mouse cochleas contain retinoic acid, at least from E14 to P0. This parallels an increase in CRABP, detected by Western blot, from E14 to P1. Interestingly, adult cochleas did not show detectable levels of retinoic acid or CRABP, although adult vestibular organs did contain retinoic acid. This may be related to the ability of adult mouse vestibular organs, but not cochleas, to regenerate hair cells following ototoxin treatment (21, 22) .
In one instance, however, retinoic acid has been reported to stimulate regeneration of cochlear hair cells in vitro. Lefebvre et al. (23) cultured adult rat cochleas following ototoxin-induced hair-cell death. Addition of retinoic acid to these cultures caused appearance of new hair cells. Because of the relevance of the results to hair-cell regeneration in humans, it will be important to extend these studies.
Thyroid Hormone in the Inner Ear
Another critical transcriptional regulator for the inner ear appears to be the receptor for thyroid hormone. There are varying reports of the extent of hearing loss in humans with congenital hypothyroidism, with 20-80% having substantial hearing loss (24, 25) . In cases of hypothyroidism produced by severe iodine deficiency, deaf-mutism is a predominant characteristic, in addition to other neurologic symptoms and disturbances in growth (26) . When rat pups are made hypothyroid by administration of propylthiouracil, there is pronounced disruption of development of the organ of Corti that includes abnormalities in the sensory epithelium and the tectorial membrane (27, 28) .
Genetic syndromes that disrupt signaling by thyroid hormone have both elucidated and confounded our understanding ofthis process. On the one hand, Pendred syndrome, an autosomal recessive condition associated with impaired thyroid hormone synthesis, has deafness as a prominent feature (29) . However, the deafness may be caused by the defect in the synthetic enzyme. In addition, a submicroscopic chromosomal deletion removing essentially all ofthe gene for TR, 8 (and presumably other genes) has no apparent phenotype in the heterozygous state but causes deafness in the homozygous state (30) . On the other hand, generalized resistance to thyroid hormone (GRTH), a more common, autosomaldominant syndrome involving >38 different mutations in the gene for TR,3, manifests as hearing loss in <5% of patients (31) . These mutations cluster in two regions of the T3-binding domain and act to reduce T3 binding to various degrees; they apparently act dominantly either by increased binding affinity of mutant homodimers for TRE combined with reduced affinity for thyroid hormone or by formation of inactive heterodimers (32) . One of the mutations, a three-base deletion that eliminates one amino acid in the T3-binding domain, abolishes thyroid hormone responsiveness and produces GRTH but does not affect hearing in heterozygote carriers nor apparently in one homozygous individual severely affected with other neurological problems (33).
Bradley et al. (1) have now used in situ hybridization to find exactly where the different TR subtypes are expressed in the developing rat inner ear. They had previously found that TRal is widely expressed in rat brain, while TRf1 occurs in some cortical regions, and TR,B2 is seen predominantly in pituitary, as expected (34, 35) . In the ear, they find a similarly restrictive pattern of the TR, types. As early as E13, TRl31 and TR,82 mRNAs are found only in the ventral otic vesicle, which gives rise to the cochlea, and not in the dorsal vesicle, which becomes the vestibular organs. At P0, when the sensory epithelium is still developing, TRal and TRa2 hybridize throughout the inner ear, whereas TR/81 and TR,32 occur only in the cochlea, and only in the region of the cochlea that forms the sensory epithelium. At P4, TR/32 hybridizes in the sensory epithelium but especially in the greater epithelial ridge (Fig. 2) 
Additional Transcription Factors
Several other genes have been identified that appear to have a role in the development of the inner ear (37) . As might be anticipated from their critical role throughout developmental processes, the homeobox genes are also implicated here. These genes (termed Hox in the mouse) encode transcriptional factors that bind to DNA homeodomains and have been implicated in a number of developmental processes involving segmentation and neurogenesis (38) . Early in mouse embryogenesis (E9-E13) the homeobox genes Hox 1.6 and 2.9, as well as the zinc-finger DNA-binding protein Krox 20 , are expressed in the fifth and sixth rhombdomeres involved in formation of the otocyst (39) . "Knock-out" mice lacking the Hox 1.6 gene manifest numerous defects in the developmental progeny of these rhombdomers with disruption of inner ear development as a predominant feature (40) (41) (42) . A promising development is the finding of three homeobox genes, Dlx-3, Msh-C, and Msh-D, expressed in the zebrafish otocyst (43) . Although lower vertebrates do not have organs with the highly specialized morphology of the mammalian cochlea, early aspects of inner ear morphogenesis are likely to be the same.
Other transcriptional factors important in inner ear development include members of the Pax family, which recognize a paired box DNA motif (38) . Mutations in the human homolog of Pax-3 cause an inherited deafness in humans, Waardenburg syndrome, which accounts for 2-5% of congenital deafness (44) (45) (46) (47) (48) . Pax-2 is also expressed in regions of the mouse otic vesicle that form neuronal components (49) . Recently, a novel member of the basic helix-loop-helix leucine zipper transcriptional family has been identified, through a mutation in the mi gene causing small eye size and early onset deafness in mice (50) . Not to be left out, the transcription factor c-fos also shows transient and stage-dependent expression in inner ear (18) .
Timed expression of these transcriptional factors is regulated in part by their ability to turn each other on and off. Retinoic acid, for example, induces sequential expression of c-fos, Krox, and Hox genes (18, 51) . Transcription factors also respond to metabolic changes instigated by growth factors. Some that appear to have a role in early inner ear development include basic fibroblast growth factor (bFGF) (52, 53) and the bFGF-related signal, int2 (54), the FGF receptor 3 (55) , and the neurotrophins BDNF, NT3, and NGF (refs. 56-60; for review see ref. 61) .
At this point in our understanding of inner ear development this vast array of transcriptional factors and growth factors strikes one more as a tempest than an orchestrated event. Elucidating the coordination and synchronization of these factors in development of the inner ear provides an enormous challenge for the future.
